3C-P Stats & Data

3C‑P is very rare and poorly characterized; assume high uncertainty. Start low, go slow, and strongly consider a 1–2 mg oral allergy test before any full dose. Come‑up is often slow (≥90 minutes), which can tempt premature redosing; wait at least 3 hours before any consideration of additional dosing. Expect sustained stimulation and possible vasoconstriction (cold or tingly extremities); avoid additional vasoconstrictors and take gentle movement breaks to promote circulation. Oral administration is preferred over insufflation to reduce nasal harm and erratic absorption. Because of long duration and residual alertness, avoid late‑day dosing and plan for sleep disruption; do not counteract with large amounts of alcohol or multiple sedatives. People with cardiovascular disease, hypertension, or arrhythmia should avoid use; monitor pulse and temperature in physically demanding settings. Use lab drug checking where available or at minimum multi‑reagent testing; the gray market has a history of mislabeling phenethylamines. Ensure accurate weighing (calibrated mg scale) and consider volumetric dilution for precise titration. Avoid driving or safety‑critical tasks for at least 16–24 hours after dosing.